SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medi-Caps to consider un-audited quarterly financial results

30 Jan 2021 Evaluate

Medi-Caps has informed that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021, to consider and approve the Standalone as well as Consolidated Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December, 2020 along with Limited Review Report; and any other matter with the permission of the chair.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

27.85 -1.63 (-5.53%)
08-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2674.75
BASF India 3340.85
Tata Chemicals 716.90
Pidilite Inds. 1459.00
Deepak Nitrite 1664.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×